C

China National Medicines Corp Ltd
SSE:600511

Watchlist Manager
China National Medicines Corp Ltd
SSE:600511
Watchlist
Price: 29.3 CNY Market Closed
Market Cap: ¥22.1B

Multiples-Based Value

The Multiples-Based Value of one China National Medicines Corp Ltd stock under the Base Case scenario is 46.67 CNY. Compared to the current market price of 29.3 CNY, China National Medicines Corp Ltd is Undervalued by 37%.

Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Multiples-Based Value
Base Case
46.67 CNY
Undervaluation 37%
Multiples-Based Value
Price ¥29.3
C
Worst Case
Base Case
Best Case

Multiples Across Competitors

Competitors Multiples
China National Medicines Corp Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
China National Medicines Corp Ltd
SSE:600511
22.1B CNY 0.4 11 7.5 7.5
US
Mckesson Corp
NYSE:MCK
107.3B USD 0.3 24.7 17.4 19.5
US
Amerisourcebergen Corp
LSE:0HF3
61.9B USD 0.2 38.1 13.5 17.1
US
Cencora Inc
NYSE:COR
61.8B USD 0.2 38.1 13.5 17.1
US
Cardinal Health Inc
NYSE:CAH
50B USD 0.2 30.1 14.5 18.9
AU
Sigma Healthcare Ltd
ASX:SIG
31.4B AUD 2.7 33.8 25.1 25.1
CN
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
63.8B CNY 0.2 11.1 8.7 8.7
CN
Huadong Medicine Co Ltd
SZSE:000963
63.7B CNY 1.5 17.2 13.3 13.3
US
Henry Schein Inc
NASDAQ:HSIC
8.5B USD 0.6 21.2 10.4 14.6
CN
Sinopharm Group Co Ltd
HKEX:1099
64B HKD 0.1 8.1 0.7 0.9
KR
Celltrion Healthcare Co Ltd
KOSDAQ:091990
12.2T KRW 5.9 89.6 59.9 61.9
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett